OTC:LMMY | Cash Flow Statement | Exousia Bio, Inc.

Complete source-backed cash-flow history.

Available history
2022-08-31 to 2025-11-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-11-30-$19,083.00
2025-08-31-$31,814.00$3,500.00$0.00-$3,500.00
2025-05-31-$29,264.00-$91,066.00$0.00$90,038.00
2025-02-28$61,833.00
2024-11-30$80,129.00
2024-08-31-$3,911.00-$3,676.00$3,676.00$0.00
2024-05-31-$5,253.00-$1,414.00$0.00$1,416.00
2024-02-29-$4,820.00
2023-11-30-$3,573.00
2023-08-31-$12,161.00-$7,951.00$0.00$1,414.00
2023-05-31-$26,775.00-$22,490.00$0.00$26,181.00
2023-02-28-$8,269.00
2022-11-30-$8,407.00
2022-08-31-$12,970.00-$9,296.00$0.00$975.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-05-31$51,395.00-$4,528.00$0.00$3,500.00
2024-05-31-$25,807.00-$12,484.00$0.00$5,657.00
2023-05-31-$56,421.00-$38,111.00$0.00$35,859.00